←Back to Expert Scholars
Translational Medicine / 转化医学Marginal Zone Lymphoma
Catherine Thieblemont
MD, PhD
🏢Hopital Saint-Louis, APHP🌐France
Professor, Hemato-Oncology Department
75
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Catherine Thieblemont is a leading authority on marginal zone lymphoma and has conducted seminal studies on splenic, nodal, and MALT subtypes within the LYSA cooperative group. Her work has defined key treatment strategies for these rare lymphomas.
Share:
🧪Research Fields 研究领域
splenic marginal zone lymphoma
MALT lymphoma
rituximab chlorambucil
LYSA cooperative group
CD20 therapy
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Catherine Thieblemont 的研究动态
Follow Catherine Thieblemont's research updates
留下邮箱，当我们发布与 Catherine Thieblemont（Hopital Saint-Louis, APHP）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment